.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Chinese Patent Office
Colorcon
Fish and Richardson
Queensland Health
Farmers Insurance
Chubb
US Department of Justice
Moodys
Healthtrust

Generated: July 23, 2017

DrugPatentWatch Database Preview

Gadobenate dimeglumine - Generic Drug Details

« Back to Dashboard

What are the generic sources for gadobenate dimeglumine and what is the scope of gadobenate dimeglumine freedom to operate?

Gadobenate dimeglumine
is the generic ingredient in two branded drugs marketed by Bracco and is included in two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for Generic Name: gadobenate dimeglumine

Tradenames:2
Patents:1
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Clinical Trials: see list23
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:gadobenate dimeglumine at DailyMed

Pharmacology for Ingredient: gadobenate dimeglumine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco
MULTIHANCE MULTIPACK
gadobenate dimeglumine
INJECTABLE;INTRAVENOUS021358-001Nov 23, 2004RXYesYes► Subscribe► Subscribe
Bracco
MULTIHANCE
gadobenate dimeglumine
INJECTABLE;INTRAVENOUS021357-004Nov 23, 2004RXYesYes► Subscribe► Subscribe
Bracco
MULTIHANCE
gadobenate dimeglumine
INJECTABLE;INTRAVENOUS021357-002Nov 23, 2004RXYesYes► Subscribe► Subscribe
Bracco
MULTIHANCE
gadobenate dimeglumine
INJECTABLE;INTRAVENOUS021357-003Nov 23, 2004RXYesYes► Subscribe► Subscribe
Bracco
MULTIHANCE MULTIPACK
gadobenate dimeglumine
INJECTABLE;INTRAVENOUS021358-002Nov 23, 2004RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: gadobenate dimeglumine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bracco
MULTIHANCE MULTIPACK
gadobenate dimeglumine
INJECTABLE;INTRAVENOUS021358-001Nov 23, 20044,916,246► Subscribe
Bracco
MULTIHANCE MULTIPACK
gadobenate dimeglumine
INJECTABLE;INTRAVENOUS021358-002Nov 23, 20044,916,246► Subscribe
Bracco
MULTIHANCE
gadobenate dimeglumine
INJECTABLE;INTRAVENOUS021357-001Nov 23, 20044,916,246► Subscribe
Bracco
MULTIHANCE
gadobenate dimeglumine
INJECTABLE;INTRAVENOUS021357-003Nov 23, 20044,916,246► Subscribe
Bracco
MULTIHANCE
gadobenate dimeglumine
INJECTABLE;INTRAVENOUS021357-004Nov 23, 20044,916,246► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Covington
Cerilliant
QuintilesIMS
McKesson
Federal Trade Commission
Boehringer Ingelheim
Queensland Health
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot